PYFAGROUP Focuses on Preventing Hypertension in Pregnant Women
Jakarta, December 18, 2024 – One of Indonesia’s leading pharmaceutical companies, PT Pyridam Farma Tbk, now known as PYFAGROUP, through
“PYFAGROUP Targets the K-Beauty Market by Partnering with a Leading Korean Beauty Company
Jakarta, November 19, 2024 – In response to the growing demand for beauty and skincare products in the Indonesian market,
Pyridam Farma (PYFA) Records Significant Growth, Revenue Doubles with a Target of Rp 3 Trillion Next Year
In its financial report released on October 31, 2024, PT Pyridam Farma Tbk (PYFA) reported a significant increase in sales
PT Pyridam Farma Tbk (PYFA) and RGCC Forge Strategic Partnership, Bringing Cancer Treatment Innovation to Indonesia
In a joint effort to combat cancer and improve access to quality treatments, PT Pyridam Farma Tbk (PYFA) and Research
INCIDENTAL PUBLIC EXPOSE OF PT PYRIDAM FARMA TBK
The Board of Directors of PT Pyridam Farma Tbk., (hereinafter referred to as the “Company”) domiciled in South Jakarta, hereby
PYFAGROUP’s Commitment to the Nation’s Health is Realized Through the Expansion of Ethica Industri Farmasi’s Injection Production Facility
Jakarta, September 12, 2024 – PT Ethica Industri Farmasi, a pharmaceutical company under the PYFAGROUP, has officially commenced the groundbreaking
Change of Corporate Secretary of PT Pyridam Farma Tbk.
Pursuant to Financial Service Authority Regulation No. 35/POJK.04/2014 regarding Corporate Secretary of Issuer or Public Company and based on Decree of the Board
PYFAGROUP Becomes the First to Launch CDMO Services in the Global Pharmaceutical Industry
Jakarta, August 9, 2024 – Anticipating the rapid growth of the health product market, PYFAGROUP, comprising leading pharmaceutical companies Pyridam